# Spectrum of Serum Sodium Disturbances in Patients With Non-sellar/Suprasellar Supratentorial Tumors

> **NCT03570203** · — · COMPLETED · sponsor: **National Institute of Mental Health and Neuro Sciences, India** · enrollment: 173 (actual)

## Conditions studied

- Supratentorial Brain Tumor

## Interventions

- **DIAGNOSTIC_TEST:** Serum Sodium

## Key facts

- **NCT ID:** NCT03570203
- **Lead sponsor:** National Institute of Mental Health and Neuro Sciences, India
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12-15
- **Primary completion:** 2014-04-30
- **Final completion:** 2014-04-30
- **Target enrollment:** 173 (ACTUAL)
- **Last updated:** 2018-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03570203

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03570203, "Spectrum of Serum Sodium Disturbances in Patients With Non-sellar/Suprasellar Supratentorial Tumors". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT03570203. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*